Pay News Feed?
Chuckle. This is a no-brainer. It's just a matter of waiting for management to get their horses in line.
It's actually a pretty depressing story. It could have been an instant (approx.) 6 bagger, if they had played the game correctly (reverse merge DGI into a public shell) and in a timely fashion.
Nah. Just watched biotechs for a long time, and notice when capitalizations get out of whack.
This is a tough one from another angle..... some weak hands, so it doesn't pay to chase it (Roach Motel, it comes back). However, DGI is bound to garner independent financing, and it currently counts as a negative toward the parent. Given the tiny capitalization of the parent relative to sales, you wind up with a unique situation. Thus, one can't chase it, but one can't afford to wait for news that looks, to some, like an eventuality. Catch 22?
Disclaimer.... all of those collectively referred to as "some", including me, may be dead wrong. Do your own homework.
Nothing if not fun!
Sorta. |
